ViewSonic’s On-the-Go Second Display TD1655, named as CES 2021 Innovation Awards Honore

One of the world’s most influential tech events, the very first all-digital CES 2021 will be occurring from January 11th to 14th, 2021. ViewSonic Corp., a leading global provider of visual solutions, is proud to share its TD1655, a portable 15.6-inch touch display, which has been selected as a CES 2021 Innovation Awards Honoree in Read more about ViewSonic’s On-the-Go Second Display TD1655, named as CES 2021 Innovation Awards Honore[…]

NOMAD Bioscience Receives Its GRAS Regulatory Clearance In USA For Plant-Made Natural Thaumatin II As Flavour Modifier

NOMAD Bioscience GmbH received a formal ‘no questions’ letter from the US Food and Drug Administration (FDA) in response to NOMAD’s GRAS notice GRN 920 describing use of plant-produced Thaumatin II as flavour modifier. Thaumatin II is natural non-caloric high intensity sweetener and flavour modifier under development at NOMAD. GRAS is a facilitated US regulatory Read more about NOMAD Bioscience Receives Its GRAS Regulatory Clearance In USA For Plant-Made Natural Thaumatin II As Flavour Modifier[…]

NOMAD BIOSCIENCE Enters Into Agreement with CTAEX, Spain, To Conduct Its First Field Trials With Plants Producing Non-Caloric Sweetener Thaumatin II in Extremadura, Spain

NOMAD BIOSCIENCE GmbH, Munich, Germany (“NOMAD”) is pleased to announce that it has entered into a research and development agreement with CENTRO TECNOLOGICO NACIONAL AGROALIMENTARIO EXTREMADURA (“CTAEX”), Badajoz, Spain. In accordance with the Agreement, CTAEX is expected to conduct in 2021 first open field trials with NOMAD plant hosts expressing Thaumatin II, a natural high-intensity Read more about NOMAD BIOSCIENCE Enters Into Agreement with CTAEX, Spain, To Conduct Its First Field Trials With Plants Producing Non-Caloric Sweetener Thaumatin II in Extremadura, Spain[…]

NOMADS UAB, Lithuania, Receives a Research Grant from Lithuanian Business Support Agency LVPA

NOMADS UAB, Vilnius, Lithuania (“NOMADS”), a wholly owned subsidiary of Nomad Bioscience GmbH, Munich, Germany, is pleased to announce that the Company has been awarded a research grant from LVPA (Lietuvos Verslo Paramos Agentūra, Lithuanian Business Support Agency) to extend its exploration of antibacterial proteins for control of multi-drug and pan-drug resistant pathogenic bacteria Klebsiella and Read more about NOMADS UAB, Lithuania, Receives a Research Grant from Lithuanian Business Support Agency LVPA[…]